Karen Flynn, President Biologics & CCO at Catalent, Inc. (CTLT), sold 3,856 shares at $112.14 ($433K) on 2021-01-11, disclosed to the SEC on 2021-01-11.
Open-market sale of $433k CTLT by President Biologics & CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.14 | 1,378 | $155K | 35.7% |
| 2 | $112.14 | 1,378 | $155K | 35.7% |
| 3 | $112.50 | 1,100 | $124K | 28.6% |
| Total | $112.24 avg | 3,856 | $433K | 100% |
| Filing → |
| CTLT | SELL | 2021-01-05 | $10K | — | Filing → |
| WST | SELL | 2018-08-09 | $4.8M | — | Filing → |
| REPH | BUY | 2016-12-19 | $5K | — | Filing → |